Metabolomics of male infertility.
Diagnosis
Infertility
Male reproductive function
Metabolomics
Therapy
Journal
Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
16
12
2023
revised:
26
02
2024
accepted:
27
02
2024
medline:
18
3
2024
pubmed:
3
3
2024
entrez:
2
3
2024
Statut:
ppublish
Résumé
This review explores the use of metabolomics in male infertility. Metabolomics, an evolving omics technology that targets the products of cellular metabolism, is valuable for elucidating underlying pathophysiology of many disorders including male infertility. The identification of reliable biomarkers is essential for accurate diagnosis and for developing precision therapeutics for those afflicted by reproductive dysfunction. Unfortunately, despite significant progress to date, the intricate relationships between these metabolic pathways and male infertility remain elusive. It is clear, however, that additional research is required to more fully characterize the role of metabolomics in this disorder and in the potential development of targeted therapies for precision medicine.
Identifiants
pubmed: 38431200
pii: S0009-8981(24)00091-3
doi: 10.1016/j.cca.2024.117850
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117850Informations de copyright
Copyright © 2024. Published by Elsevier B.V.